advertisement
Abstract #10313 Published in IGR 6-1
Enhanced expression of cyclooxygenase-2 in glaucomatous dog eyes
Marshall JL; Stanfield KM; Silverman L; Khan KNVeterinary Ophthalmology 2004; 7: 59-62
OBJECTIVE: Cyclooxygenase-2 (COX-2)-derived prostaglandins (PGs) are shown to play important pathophysiological roles in various disease states. Recently, the effectiveness of topical PGs in reducing intraocular pressure (IOP) has stimulated further interest in the physiological function of COX-2 and PGs in normal and glaucomatous eyes. Therefore, the authors investigated the cell-type distribution and expression of COX-2 in normal and glaucomatous dog eyes. PROCEDURES: Using isoform-specific antibodies, they immunohistochemically evaluated COX-2 expression in formalin-fixed and paraffin-embedded normal (n = 5) and glaucomatous (n = 17) dog eyes. RESULTS: In the normal eyes, only minimal COX-2 immunoreactivity was observed in the ciliary epithelium. In the glaucomatous eyes, COX-2 expression was further observed in the cornea and corneoscleral limbus. In the cornea, moderate to strong COX-2 expression was observed in all corneal layers (epithelium, stromal cells and endothelium), with the greatest expression present in the epithelial layer. In the corneoscleral limbus area, COX-2 immunoreactivity was noted in the stromal cells of sclera, trabecular meshwork and endothelial cells of the angular aqueous plexus. CONCLUSIONS: Increased expression of COX-2 in dog glaucomatous eyes suggests that COX-2-derived PGs may have a potential role in the pathogenesis of canine glaucoma.
Dr. J.L. Marshall, Pfizer Research & Development, 4901 Searle Parkway, Skokie, IL 60077, USA.
Classification:
5 Experimental glaucoma; animal models
11.4 Prostaglandins (Part of: 11 Medical treatment)
